Responses
ePoster Viewing: Trials-in-Progress
AS03. Cervical cancer
TP003/#1557 An open label, single arm, multicenter trial of durvalumab and BVAC-C, in patients with HPV 16 or 18 positive cervical cancer (DURBAC)
Compose a Response to This Article
Other responses
No responses have been published for this article.